Syros Pharmaceuticals, Inc. - common stock (SYRS): Price and Financial Metrics
SYRS Price/Volume Stats
| Current price | $0.02 | 52-week high | $0.10 |
| Prev. close | $0.03 | 52-week low | $0.02 |
| Day low | $0.02 | Volume | 249,990 |
| Day high | $0.03 | Avg. volume | 556,339 |
| 50-day MA | $0.00 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 536.64K |
SYRS Stock Price Chart Interactive Chart >
Syros Pharmaceuticals, Inc. - common stock (SYRS) Company Bio
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing medicines that control genes to transform the lives of patients with cancer, immune-mediated diseases, and other diseases. The company was founded in 2011 and is based in Cambridge, Massachusetts.
SYRS Price Returns
| 1-mo | -76.69% |
| 3-mo | -90.24% |
| 6-mo | -98.98% |
| 1-year | -99.64% |
| 3-year | N/A |
| 5-year | -99.98% |
| YTD | -91.30% |
| 2024 | -97.05% |
| 2023 | 116.99% |
| 2022 | -88.99% |
| 2021 | -69.95% |
| 2020 | 57.02% |
Continue Researching SYRS
Want to see what other sources are saying about Syros Pharmaceuticals Inc's financials and stock price? Try the links below:Syros Pharmaceuticals Inc (SYRS) Stock Price | Nasdaq
Syros Pharmaceuticals Inc (SYRS) Stock Quote, History and News - Yahoo Finance
Syros Pharmaceuticals Inc (SYRS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...